Why the study?
Does high thoracic epidural anesthesia improve cardiac structure, function, and autonomic neural function in patients with ischemic cardiomyopathy and chronic heart failure?
Does high thoracic epidural anesthesia improve cardiac structure, function, and autonomic neural function in patients with ischemic cardiomyopathy and chronic heart failure?
High thoracic epidural anesthesia added to medical therapy for 4 weeks improves echocardiographic and electrocardiographic surrogate markers of cardiac function and autonomic tone in patients with ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
HTEA may improve surrogates in ischemic cardiomyopathy; leaves open effects on outcomes and requires randomized confirmation.
We aimed at observing the effects of high thoracic epidural anesthesia (HTEA) on cardiac structure and function, heart rate variability (HRV), and QT interval variation (QTV) in ischemic cardiomyopathy (ICM) patients with chronic heart failure. We divided 30 ICM patients into HTEA (N = 16) and control (N = 14) groups.The control group was treated with medication, and the HTEA group was treated with HTEA and medication for 4 weeks. We measured the changes in the left-ventricular end-diastolic diameter (LVEDd) and left-ventricular ejection fraction (LVEF) before and after treatment by using echocardiography and examined changes in HRV and QTV using ambulatory electrocardiogram. HTEA significantly narrowed the LVEDd, improved LVEF, significantly increased the HRV, and significantly reduced the QTV in the ICM group compared to the control group. HTEA significantly narrowed the ventricular chamber diameter size of ICM patients, enhanced myocardial contractility, increased myocardial electrical stability, and improved the cardiac structure and function.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: